Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#892 most reported symptom for this vaccine
Blood immunoglobulin M increased has been reported 12 times in association with Hepatitis A (Vaqta) vaccination in VAERS. This represents 0.0% of all 48,094 reports for this vaccine.
Among these reports, 1 mentioned death (8.33%) and 2 involved hospitalization (16.7%).
Blood immunoglobulin M increased is the #892 most frequently reported symptom for Hepatitis A (Vaqta) out of 2056 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 12 reports of Blood immunoglobulin M increased after Hepatitis A (Vaqta) vaccination may seem alarming, but context is critical.
The 8.33% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.